These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2017069)

  • 41. Border crossing.
    Fuller C
    Revolution (Oakl); 2003; 4(5):24-9. PubMed ID: 14631721
    [No Abstract]   [Full Text] [Related]  

  • 42. [Class substitution of medicines--between cost reduction and the position of professionals in health care].
    Cohen AF
    Ned Tijdschr Geneeskd; 2002 Mar; 146(12):551-3. PubMed ID: 11938576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Maximum Allowable Cost program--some marketing consequences.
    Gosselin RA
    Med Mark Media; 1978 Feb; 13(2):19-20, 22, 24 passim. PubMed ID: 10306394
    [No Abstract]   [Full Text] [Related]  

  • 44. [Factors determining the rise in costs of drugs in Socio-Medical Services].
    Ramos VM
    Acta Med Port; 1981; 3(5-6):363-70. PubMed ID: 7340405
    [No Abstract]   [Full Text] [Related]  

  • 45. DAKOTACARE update: What are we doing about prescription costs?
    Krafka TL
    S D Med; 2007 Jun; 60(6):243-4. PubMed ID: 17649865
    [No Abstract]   [Full Text] [Related]  

  • 46. Public policy considerations in the pricing of prescription drugs in the United States.
    Rucker TD
    Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895
    [No Abstract]   [Full Text] [Related]  

  • 47. "Maximum allowable cost" effective date delayed.
    Employee Benefit Plan Rev; 1976 Jun; 30(12):12, 14. PubMed ID: 1037550
    [No Abstract]   [Full Text] [Related]  

  • 48. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rational use of drugs].
    Viana Alonso A; Iñesta García A
    Rev Sanid Hig Publica (Madr); 1993; 67(4):325-6. PubMed ID: 7732298
    [No Abstract]   [Full Text] [Related]  

  • 50. The economics of drug prescribing in Ireland.
    O'Hanrahan M; O'Malley K
    Ir Med J; 1981 Oct; 74(10):309-10, 312. PubMed ID: 7309452
    [No Abstract]   [Full Text] [Related]  

  • 51. Generic drugs provide no big savings so far in nation's health bill.
    Lublin JS; Jaroslovsky R
    Wall St J Midwest Ed; 1978 Dec; 59(38):1, 19. PubMed ID: 10239001
    [No Abstract]   [Full Text] [Related]  

  • 52. Higher profile puts them in the crosshairs.
    Calandra R
    Manag Care; 2016 Dec; 25(12):28-29. PubMed ID: 28121556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent trends in drug prescribing rates and costs in New Zealand.
    Malcolm LA; Mehl A
    N Z Med J; 1988 May; 101(845):233-6. PubMed ID: 3368132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. How to restrain ballooning drug benefit costs.
    Vibbert S
    Bus Health; 1989 Apr; 7(4):38-41, 43-6. PubMed ID: 10293138
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of a Medicaid program on prescription drug availability and acquisition.
    Smith MC; Garner DD
    Med Care; 1974 Jul; 12(7):571-81. PubMed ID: 4600309
    [No Abstract]   [Full Text] [Related]  

  • 56. [The physician, the pharmacist and magistral preparations].
    Scholten WK; Tel H
    Ned Tijdschr Geneeskd; 1991 May; 135(20):885-9. PubMed ID: 2046789
    [No Abstract]   [Full Text] [Related]  

  • 57. [Calculation and evaluation of medical prescriptions by mechanical data processing].
    Bretschneider K; Voss H
    Pharm Prax; 1969; 8():Suppl 8:169+. PubMed ID: 5348227
    [No Abstract]   [Full Text] [Related]  

  • 58. Reimbursement methods for pharmaceutical service.
    Gagnon JP; Rodowskas CA
    J Am Pharm Assoc; 1974 Dec; 14(12):675-8. PubMed ID: 4436520
    [No Abstract]   [Full Text] [Related]  

  • 59. Do drug copayments work?
    David J
    CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
    [No Abstract]   [Full Text] [Related]  

  • 60. The pharmaceutical market and prescription drugs in the Federal Republic of Germany: cross-national comparisons.
    Schicke RK
    Int J Health Serv; 1973; 3(2):223-36. PubMed ID: 4197751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.